1.
Mangaonkar AA, Lasho TL, Finke C, Ketterling RP, Reichard KK, McCullough K, Gangat N, Al-Kali A, Begna KH, Hogan WH, Litzow MR, Alkhateeb H, Shah M, Pardanani A, Tefferi A, Al Ali NH, Talati C, Sallman D, Padron E, Komrokji R, Patnaik MM. <i>SF3B1</i&gt;-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity. haematol [Internet]. 2022Feb.10 [cited 2022May19];107(5):1189-92. Available from: https://haematologica.org/article/view/haematol.2021.280463